Schedule 13D ownership disclosure
IMPRIMIS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 45323A201
Event date: 2016-08-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-16-012984
- Form type
- SC 13D
- Filer
- HARROW, INC.
- CIK
- CIK 1360214
- Filed
- Aug 30, 2016
- Reporting period
- Aug 19, 2016
- Description
- Schedule 13D beneficial ownership